Literature DB >> 23132271

Convergent findings for abnormalities of the NF-κB signaling pathway in schizophrenia.

Panos Roussos1, Pavel Katsel, Kenneth L Davis, Stella G Giakoumaki, Todd Lencz, Anil K Malhotra, Larry J Siever, Panos Bitsios, Vahram Haroutunian.   

Abstract

Neurons exhibit a constitutive level of nuclear factor-κB (NF-κB) signaling and this pathway plays a significant role in neurite outgrowth, activity-dependent plasticity, and cognitive function. Transcription factor analysis was performed in a microarray data set profiled in four different brain regions (n=54 comparison group; n=53 schizophrenia (SZ)). An independent postmortem cohort was used for gene expression (n=24 comparison group; n=22 SZ), protein abundance (n=8 comparison group; n=8 SZ), and NF-κB nuclear activity (n=10 comparison group; n=10 SZ) quantification. Expression quantitative trait locus analysis was performed using publicly available data. Prepulse inhibition (PPI) of the acoustic startle reflex was tested in healthy individuals (n=690). Comparison of microarray data showed that NF-κB was among the transcription factors associated with the differential expression of genes in cases vs controls. NF-κB gene and protein levels and nuclear activation were significantly decreased in the superior temporal gyrus of patients with SZ. Upstream NF-κB genes related to translocation were significantly dysregulated in SZ. The gene expression levels of an NF-κB-associated importin (KPNA4: one of the proteins responsible for the translocation of NF-κB to the nucleus) was decreased in SZ and an SNP within the KPNA4 locus was associated with susceptibility to SZ, reduced KPNA4 expression levels and attenuated PPI of the startle reflex in healthy control subjects. These findings implicate abnormalities of the NF-κB signaling pathway in SZ and provide evidence for an additional possible mechanism affecting the translocation of NF-κB signaling to the nucleus.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23132271      PMCID: PMC3547205          DOI: 10.1038/npp.2012.215

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  49 in total

Review 1.  Translating glutamate: from pathophysiology to treatment.

Authors:  Daniel C Javitt; Darryle Schoepp; Peter W Kalivas; Nora D Volkow; Carlos Zarate; Kalpana Merchant; Mark F Bear; Daniel Umbricht; Mihaly Hajos; William Z Potter; Chi-Ming Lee
Journal:  Sci Transl Med       Date:  2011-09-28       Impact factor: 17.956

2.  Principal components analysis corrects for stratification in genome-wide association studies.

Authors:  Alkes L Price; Nick J Patterson; Robert M Plenge; Michael E Weinblatt; Nancy A Shadick; David Reich
Journal:  Nat Genet       Date:  2006-07-23       Impact factor: 38.330

3.  Developmental regulation of sensory neurite growth by the tumor necrosis factor superfamily member LIGHT.

Authors:  Núria Gavaldà; Humberto Gutierrez; Alun M Davies
Journal:  J Neurosci       Date:  2009-02-11       Impact factor: 6.167

4.  Neural progenitor number is regulated by nuclear factor-kappaB p65 and p50 subunit-dependent proliferation rather than cell survival.

Authors:  Kaylene M Young; Perry F Bartlett; Elizabeth J Coulson
Journal:  J Neurosci Res       Date:  2006-01       Impact factor: 4.164

5.  Complete lack of NF-kappaB activity in IKK1 and IKK2 double-deficient mice: additional defect in neurulation.

Authors:  Q Li; G Estepa; S Memet; A Israel; I M Verma
Journal:  Genes Dev       Date:  2000-07-15       Impact factor: 11.361

6.  NF-{kappa}B is transported into the nucleus by importin {alpha}3 and importin {alpha}4.

Authors:  Riku Fagerlund; Leena Kinnunen; Matthias Köhler; Ilkka Julkunen; Krister Melén
Journal:  J Biol Chem       Date:  2005-01-27       Impact factor: 5.157

7.  Nuclear factor-kappaB is a critical mediator of stress-impaired neurogenesis and depressive behavior.

Authors:  Ja Wook Koo; Scott J Russo; Deveroux Ferguson; Eric J Nestler; Ronald S Duman
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-26       Impact factor: 11.205

8.  A risk PRODH haplotype affects sensorimotor gating, memory, schizotypy, and anxiety in healthy male subjects.

Authors:  Panos Roussos; Stella G Giakoumaki; Panos Bitsios
Journal:  Biol Psychiatry       Date:  2009-02-20       Impact factor: 13.382

9.  Diffusion tensor imaging findings in first-episode and chronic schizophrenia patients.

Authors:  Joseph I Friedman; Cheuk Tang; David Carpenter; Monte Buchsbaum; James Schmeidler; Lauren Flanagan; Shana Golembo; Isabella Kanellopoulou; Johnny Ng; Patrick R Hof; Philip D Harvey; Nicholas D Tsopelas; Daniel Stewart; Kenneth L Davis
Journal:  Am J Psychiatry       Date:  2008-06-16       Impact factor: 18.112

10.  Population structure and eigenanalysis.

Authors:  Nick Patterson; Alkes L Price; David Reich
Journal:  PLoS Genet       Date:  2006-12       Impact factor: 5.917

View more
  25 in total

1.  Network analysis of gene expression in peripheral blood identifies mTOR and NF-κB pathways involved in antipsychotic-induced extrapyramidal symptoms.

Authors:  S Mas; P Gassó; E Parellada; M Bernardo; A Lafuente
Journal:  Pharmacogenomics J       Date:  2015-01-27       Impact factor: 3.550

Review 2.  Behavioral sequelae of astrocyte dysfunction: focus on animal models of schizophrenia.

Authors:  Meng Xia; Sofya Abazyan; Yan Jouroukhin; Mikhail Pletnikov
Journal:  Schizophr Res       Date:  2014-11-20       Impact factor: 4.939

Review 3.  Diversification of importin-α isoforms in cellular trafficking and disease states.

Authors:  Ruth A Pumroy; Gino Cingolani
Journal:  Biochem J       Date:  2015-02-15       Impact factor: 3.857

4.  The triggering receptor expressed on myeloid cells 2 (TREM2) is associated with enhanced inflammation, neuropathological lesions and increased risk for Alzheimer's dementia.

Authors:  Panos Roussos; Pavel Katsel; Peter Fam; Weilun Tan; Dushyant P Purohit; Vahram Haroutunian
Journal:  Alzheimers Dement       Date:  2014-12-09       Impact factor: 21.566

5.  Transcriptome-wide mega-analyses reveal joint dysregulation of immunologic genes and transcription regulators in brain and blood in schizophrenia.

Authors:  Jonathan L Hess; Daniel S Tylee; Rahul Barve; Simone de Jong; Roel A Ophoff; Nishantha Kumarasinghe; Paul Tooney; Ulrich Schall; Erin Gardiner; Natalie Jane Beveridge; Rodney J Scott; Surangi Yasawardene; Antionette Perera; Jayan Mendis; Vaughan Carr; Brian Kelly; Murray Cairns; Ming T Tsuang; Stephen J Glatt
Journal:  Schizophr Res       Date:  2016-07-20       Impact factor: 4.939

6.  Interaction between TSPO-a neuroimmune marker-and redox status in clinical high risk for psychosis: a PET-MRS study.

Authors:  Sina Hafizi; Tania Da Silva; Jeffrey H Meyer; Michael Kiang; Sylvain Houle; Gary Remington; Ivana Prce; Alan A Wilson; Pablo M Rusjan; Napapon Sailasuta; Romina Mizrahi
Journal:  Neuropsychopharmacology       Date:  2018-04-13       Impact factor: 7.853

7.  Linking proteomic alterations in schizophrenia hippocampus to NMDAr hypofunction in human neurons and oligodendrocytes.

Authors:  Giuliana S Zuccoli; Guilherme Reis-de-Oliveira; Bruna Garbes; Peter Falkai; Andrea Schmitt; Helder I Nakaya; Daniel Martins-de-Souza
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2021-03-10       Impact factor: 5.270

8.  The Schizophrenia-Related Protein Dysbindin-1A Is Degraded and Facilitates NF-Kappa B Activity in the Nucleus.

Authors:  Cheng Fu; Dong Chen; Ruijie Chen; Qingsong Hu; Guanghui Wang
Journal:  PLoS One       Date:  2015-07-14       Impact factor: 3.240

9.  Adjunctive Aspirin vs Placebo in Patients With Schizophrenia: Results of Two Randomized Controlled Trials.

Authors:  Mark Weiser; Daisy Zamora; Linda Levi; Igor Nastas; Ilan Gonen; Paull Radu; Valentin Matei; Anatol Nacu; Larisa Boronin; Michael Davidson; John M Davis
Journal:  Schizophr Bull       Date:  2021-07-08       Impact factor: 9.306

10.  Exploring the neuropsychiatric spectrum using high-content functional analysis of single-cell signaling networks.

Authors:  Santiago G Lago; Jakub Tomasik; Geertje F van Rees; Jordan M Ramsey; Frieder Haenisch; Jason D Cooper; Jantine A Broek; Paula Suarez-Pinilla; Tillmann Ruland; Bonnie Auyeug; Olya Mikova; Nikolett Kabacs; Volker Arolt; Simon Baron-Cohen; Benedicto Crespo-Facorro; Sabine Bahn
Journal:  Mol Psychiatry       Date:  2018-07-23       Impact factor: 13.437

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.